跳至主要内容
临床试验/CTRI/2011/07/001886
CTRI/2011/07/001886已完成2 期

Randomized, double blind, parallel group, placebo controlled study to evaluate the safety and efficacy of Arthronat in subjects with painful Osteoarthritis of hips, knees, shoulders, neck or wrists

Rowtasha0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • A previously diagnosed (atleast 3 months prior to the screening visit) case of osteoarthritis of hip, knees based on the ACR Clinical Classification criteria for osteoarthritis
  • A previously diagnosed (atleast 3 months prior to screening visit) case on shoulders, neck and wrists based on the clinical and radiographic findings.

排除标准

  • Subject with history of disease which may involve the index joint including but not
  • limited to rheumatoid arthritis
  • Any inflammatory joint disease
  • Metabolic bone disease (gout, pseudo gout etc)
  • Bone tumours
  • Joint infections (reactive arthritis, septic arthritis)
  • Avascular necrosis (especially of neck of femur)
  • Neuropathic disorders etc.

研究者

发起方
Rowtasha

相似试验

进行中(未招募)
不适用
Randomized, double blind, parallel groups, placebo controlled pivotal clinical trial to asses preliminary efficacy and security of a sublingual Cannabis Standardized Extract (Sativex) added to reference treatment for prevention and treatment of nausea and late vomiting induced by moderately emetogenic chemotherapy. - SATEME-08Chemotherapy induced nausea and vomiting
EUCTR2004-003824-36-ESFundació Institut Català de Farmacologia
进行中(未招募)
1 期
Multicenter clinical trial to evaluate efficacy and safety of diclofenac 1% gel produced by Epifarma s.r.l. compared to Voltaren® Emulgel® 1% gelPatients with acute painful and flogistic (inflammatory) disease due to acute traumatic events (injury/contusion) of joints, muscles, tendons and ligaments
EUCTR2015-001779-29-HUEpifarma s.r.l.749
进行中(未招募)
1 期
Elsiglutide will be administered to patients with colorectal cancer along with chemotherapy, to assess the efficacy of elsiglutide in preventing the Chemotherapy Induced Diarrhea (CID). Elsiglutide will be given at different doses including placebo group.Chemotherapy Induced Diarrhea (CID)MedDRA version: 18.0Level: LLTClassification code 10056985Term: Diarrhoea post chemotherapySystem Organ Class: 100000004856
EUCTR2014-000998-39-BGHelsinn Healthcare SA600
进行中(未招募)
1 期
Multicenter clinical trial to evaluate efficacy and safety of diclofenac 1% gel produced by Epifarma s.r.l. compared to Voltaren¿ Emulgel¿ 1% gel
EUCTR2015-001779-29-ITEPIFARMA S.R.L.749
进行中(未招募)
1 期
Multicenter clinical trial to evaluate efficacy and safety of diclofenac 1% gel produced by Epifarma s.r.l. compared to Voltaren® Emulgel® 1% gelPatients with acute painful and flogistic (inflammatory) disease due to acute traumatic events (injury/contusion) of joints, muscles, tendons and ligaments
EUCTR2015-001779-29-DEEpifarma s.r.l.749
Safety and Efficacy of Arthronat in subjects with... | 临床试验